The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 320.00
Bid: 323.00
Ask: 324.50
Change: 2.50 (0.79%)
Spread: 1.50 (0.464%)
Open: 319.50
High: 332.50
Low: 319.50
Prev. Close: 317.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Biomedica PLC - Block Listing Return

3 Jul 2023 07:00

RNS Number : 6510E
Oxford Biomedica PLC
03 July 2023
 

For Immediate Release 3 July 2023

OXFORD BIOMEDICA PLC

BLOCK LISTING RETURN

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2023

To:

30 June 2023

Balance of unallotted securities under scheme(s) from previous return:

331,574

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

22,148

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

309,426

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2023

To:

30 June 2023

Balance of unallotted securities under scheme(s) from previous return:

339,319

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

300,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

196,342

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

442,977

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2023

To:

30 June 2023

Balance of unallotted securities under scheme(s) from previous return:

202,445

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

100,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

6,173

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

296,272

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2023

To:

30 June 2023

Balance of unallotted securities under scheme(s) from previous return:

331,484

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

100,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

91,731

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFSRDVIFIIV
Date   Source Headline
28th Sep 202110:01 amRNSTotal Voting Rights
22nd Sep 20217:38 amRNSStrategic investment by Serum Life Sciences
22nd Sep 20217:00 amRNSInterim Results
1st Sep 202110:48 amRNSTotal Voting Rights
1st Sep 20217:00 amRNSNotice of Interim Results
3rd Aug 20212:20 pmRNSLTIP Option Grant
2nd Aug 202111:16 amRNSTotal Voting Rights
15th Jul 20217:00 amRNSNon-Executive Director Appointment
6th Jul 20213:10 pmRNSDirector/PDMR Shareholding
1st Jul 202111:35 amRNSBlock listing Return
1st Jul 202110:43 amRNSTotal Voting Rights
24th Jun 20211:05 pmRNSDirectors Dealings / Market Share Purchases
9th Jun 202110:36 amRNSHolding(s) in Company
8th Jun 20212:32 pmRNSGrant of options
1st Jun 202110:13 amRNSTotal Voting Rights
28th May 20217:00 amEQSOxford Biomedica (OXB): Driving innovation in a thriving CGT industry
28th May 20217:00 amRNSBlock Listing Application
28th May 20217:00 amRNSResult of AGM
27th May 20217:00 amRNSBoard Change
25th May 20219:21 amRNSDirector/PDMR Shareholding
21st May 202112:46 pmRNSPDMR Dealing
20th May 202111:42 amRNSPDMR Dealings
18th May 20217:00 amRNSOxford Biomedica upgrades financial guidance
10th May 202110:54 amRNSHolding(s) in Company
4th May 202110:29 amRNSTotal Voting Rights
4th May 202110:27 amRNSHoldings in Company
27th Apr 20212:40 pmRNS2020 Annual report and Accounts & AGM Notification
26th Apr 202112:32 pmRNSHolding(s) in Company
15th Apr 20217:00 amRNSFull year results
6th Apr 20217:00 amRNSOXB signs Agreement with Boehringer Ingelheim
1st Apr 202111:04 amRNSTotal Voting Rights
30th Mar 202110:22 amRNSHolding(s) in Company
19th Mar 20217:01 amRNSUpdate on Sanofi Collaboration & License Agreement
15th Mar 202110:03 amRNSNotice of Preliminary Results
1st Mar 20219:36 amRNSTotal Voting Rights
26th Feb 202110:46 amRNSPDMR Dealings / Market Share sale
5th Feb 20211:22 pmRNSHoldings in Company
3rd Feb 20217:00 amRNSBoard Changes
1st Feb 20219:47 amRNSTotal Voting Rights
4th Jan 20212:09 pmRNSBlock Listing Return
4th Jan 20211:41 pmRNSTotal Voting Rights
30th Dec 20209:03 amRNSOXB notes AZ vaccine has been authorised in the UK
1st Dec 202012:17 pmRNSDirector Dealings
1st Dec 20209:02 amRNSTotal Voting Rights
23rd Nov 20208:47 amRNSOXB notes AZD1222 met primary efficacy endpoint
23rd Nov 20207:00 amRNSNon-Executive Director Appointment
9th Nov 20207:00 amRNSOXB and PhoreMost enter gene therapy collaboration
2nd Nov 20209:02 amRNSTotal Voting Rights
30th Oct 20207:00 amRNSAxovant update on AXO-Lenti-PD and virtual R&D day
23rd Oct 202010:27 amRNSDirector Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.